Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

Can I buy Intrinsic Medicine stock?

Intrinsic Medicine will no longer be going public. But you can still buy stock in similar companies.

Intrinsic Medicine, which develops treatments for gut-related conditions using synthetic biology-manufactured human identical milk oligosaccharide (HiMO) molecules, has cancelled plans to go public in the US. Learn more about the withdrawn IPO, and find out about similar companies in which you can invest.

Alternative pick for crypto trading

Go to site
  • $0 commission trading
  • Instant withdrawals with a 1.75% fee
  • Supports 250+ cryptocurrencies
  • High-yield account earns up to 4.65% APY
Terms apply. Cryptoassets are highly volatile. Your capital is at risk. Available in the US, CA, UK and AU

Disclaimer: This page is not financial advice or an endorsement of digital assets, providers or services. Digital assets are volatile and risky, and past performance is no guarantee of future results. Potential regulations or policies can affect their availability and services provided. Talk with a financial professional before making a decision. Finder or the author may own cryptocurrency discussed on this page.

Top pick for advanced traders

Go to site
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Top pick for best mobile experience

Go to site
  • Trade $0 commission stocks, ETFs, and options with as little as $1
  • After-hours trading available
  • Earn 4.5% interest on uninvested cash with Gold
  • 24/7 customer support

What we know about the Intrinsic Medicine IPO

On July 25, 2022, Intrinsic Medicine announced it was cancelling its plans to go public. Originally, it had planned to conduct an IPO on the Nasdaq under the ticker symbol “INRX.” Altogether, the company had planned to raise around $25 million by offering 4.2 million stocks at a price of $5.00 – $7.00.

Spartan Capital Securities, LLC was slated to act as the lead underwriter of the deal. You can read more about the IPO in this prospectus submitted to the US Securities and Exchange Commission (SEC) on May 4, 2022.

Current market conditions have been cited as the reason for for the cancellation. A future IPO date has not been announced.

Buy stocks in similar companies

Even though you won’t be able to buy Intrinsic Medicine stock, you can still invest in other biotechnology companies that develop treatments for gut-related conditions.

CompanyStock info
Finch Therapeutics GroupNasdaqGS: FNCH
Seres TherapeuticsNasdaqGS: MCRB
Evelo BiosciencesNasdaqGS: EVLO
PureTech HealthNasdaqGM: PRTC

How to buy stocks in a company

You’ll need a brokerage account to buy and sell stocks. Here’s how it works:

  1. Compare stock trading platforms. Use our comparison table to help you find a platform with the features you want and fees you can afford.
  2. Open your brokerage account. Complete an application by providing your personal, contact and financial details as well as your Social Security number.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol (for example, “FNCH”), and research it before deciding if it’s a good investment for you.
  5. Purchase now or later. Buy your desired number of stocks with a market order, or use a limit order to delay your purchase until the stock reaches a more favorable price.

Open a stock trading account

1 - 8 of 10
Name Product USFST Available asset types Annual advisory fee Signup bonus
Tastytrade
Finder Score: 4.4 / 5: ★★★★★
Tastytrade
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
0%
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
Robinhood
Finder Score: 4.6 / 5: ★★★★★
Robinhood
Stocks, Options, ETFs, Cryptocurrency
0%
Get a free stock
Trade stocks, options, ETFs and crypto without commissions and on a user-friendly platform. Plus, a 1% IRA match and no options contract fees.
SoFi Invest®
Finder Score: 4.3 / 5: ★★★★★
SoFi Invest®
Stocks, Options, Mutual funds, ETFs, Alternatives
0.25%
Get up to $1,000 in stock
Zero-commission stocks, ETFs and options, with no options per-contract fees. Plus, a complimentary access to financial planners.
OPTO
Finder Score: 3.8 / 5: ★★★★★
OPTO
Stocks, ETFs
$0 per month
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
eToro
Finder Score: 4.3 / 5: ★★★★★
EXCLUSIVE
eToro
Stocks, Options, ETFs, Cryptocurrency
0%
FINDER EXCLUSIVE: Get a guaranteed $15 bonus and $10 in free crypto
No commission stock, ETF and options trades, with 4.9% interest on your options account balance and no options contract fees.
Public.com
Finder Score: 4.4 / 5: ★★★★★
Public.com
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
0%
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.
Stash
Finder Score: 3.7 / 5: ★★★★★
Stash
Stocks, ETFs
$3 per month
Get $10 when you sign up and deposit $5
Automated investing, individual stock and ETF investing and banking services for as low as $3 per month.
Wealthfront
Finder Score: 4.5 / 5: ★★★★★
Wealthfront
Stocks, ETFs
0.25%
Get $50
Automated stock and bond ETF investing with the ability to trade individual stocks for as little as $1 apiece.
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

More on investing

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site